KA
Kintegral Advisory’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.43M | Sell |
19,340
-29
| -0.1% | -$3.64K | 0.22% | 111 |
|
|
2025
Q1 | $2.65M | Sell |
19,369
-66
| -0.3% | -$9.03K | 0.27% | 101 |
|
|
2024
Q4 | $2.97M | Sell |
19,435
-905
| -4% | -$138K | 0.28% | 97 |
|
|
2024
Q3 | $3.94M | Sell |
20,340
-266
| -1% | -$51.6K | 0.36% | 86 |
|
|
2024
Q2 | $4.78M | Buy |
20,606
+7,885
| +62% | +$1.83M | 0.46% | 61 |
|
|
2024
Q1 | $2.74M | Sell |
12,721
-40
| -0.3% | -$8.63K | 0.27% | 96 |
|
|
2023
Q4 | $3.3M | Sell |
12,761
-81
| -0.6% | -$21K | 0.37% | 81 |
|
|
2023
Q3 | $3.3M | Sell |
12,842
-8
| -0.1% | -$2.06K | 0.41% | 70 |
|
|
2023
Q2 | $3.66M | Hold |
12,850
| – | – | 0.43% | 70 |
|
|
2023
Q1 | $3.57M | Sell |
12,850
-690
| -5% | -$192K | 0.46% | 69 |
|
|
2022
Q4 | $3.75M | Buy |
13,540
+5,262
| +64% | +$1.46M | 0.5% | 64 |
|
|
2022
Q3 | $2.21M | Hold |
8,278
| – | – | 0.31% | 87 |
|
|
2022
Q2 | $1.69M | Buy |
8,278
+175
| +2% | +$35.7K | 0.22% | 110 |
|
|
2022
Q1 | $1.71M | Buy |
8,103
+182
| +2% | +$38.3K | 0.19% | 117 |
|
|
2021
Q4 | $1.9M | Hold |
7,921
| – | – | 0.2% | 114 |
|
|
2021
Q3 | $2.24M | Hold |
7,921
| – | – | 0.26% | 92 |
|
|
2021
Q2 | $2.74M | Hold |
7,921
| – | – | 0.32% | 78 |
|
|
2021
Q1 | $2.22M | Hold |
7,921
| – | – | 0.28% | 91 |
|
|
2020
Q4 | $1.94M | Hold |
7,921
| – | – | 0.26% | 97 |
|
|
2020
Q3 | $2.25M | Sell |
7,921
-255
| -3% | -$72.3K | 0.34% | 75 |
|
|
2020
Q2 | $2.19M | Hold |
8,176
| – | – | 0.35% | 75 |
|
|
2020
Q1 | $2.59M | Buy |
8,176
+916
| +13% | +$290K | 0.5% | 53 |
|
|
2019
Q4 | $2.15M | Hold |
7,260
| – | – | 0.39% | 76 |
|
|
2019
Q3 | $1.69M | Hold |
7,260
| – | – | 0.34% | 86 |
|
|
2019
Q2 | $1.7M | Hold |
7,260
| – | – | 0.34% | 85 |
|
|
2019
Q1 | $1.72M | Sell |
7,260
-463
| -6% | -$109K | 0.36% | 83 |
|
|
2018
Q4 | $2.32M | Buy |
+7,723
| New | +$2.32M | 0.69% | 37 |
|